Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Crocker

Showing results (291-300 of 308) with videos related to

Pageof 31
Sort By:
Journal of Neuro-Oncology|December 22, 2016
Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysisKirtesh R Patel, Stuart H Burri, Danielle Boselli, et al.
Journal of Neurosurgery|April 21, 2018
Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastasesJaymin Jhaveri, Mudit Chowdhary, Xinyan Zhang, et al.
Neurosurgery|November 4, 2015
Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional AnalysisKirtesh R Patel, Stuart H Burri, Anthony L Asher, et al.
Practical Radiation Oncology|October 7, 2019
Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain MetastasesDaniel G Tanenbaum, Zachary S Buchwald, Jaymin Jhaveri, et al.
Scientific Reports|May 2, 2020
Genomic copy number variation correlates with survival outcomes in WHO grade IV gliomaZachary S Buchwald, Sibo Tian, Michael Rossi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain MetastasesRobert H Press, Danielle M Boselli, James T Symanowski, et al.
Cell Reports|February 10, 2018
Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8<sup>+</sup> T Cell Cross-PrimingDieke van Dinther, Henrike Veninga, Salvador Iborra, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2016
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cellsMaurizio Perdicchio, Juan M Ilarregui, Marleen I Verstege, et al.
Journal of Neuro-Oncology|November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgeryMudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.
Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Pageof 31

Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Journal of Neuro-Oncology|December 22, 2016
Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysisKirtesh R Patel, Stuart H Burri, Danielle Boselli, et al.
Journal of Neurosurgery|April 21, 2018
Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastasesJaymin Jhaveri, Mudit Chowdhary, Xinyan Zhang, et al.
Neurosurgery|November 4, 2015
Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional AnalysisKirtesh R Patel, Stuart H Burri, Anthony L Asher, et al.
Practical Radiation Oncology|October 7, 2019
Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain MetastasesDaniel G Tanenbaum, Zachary S Buchwald, Jaymin Jhaveri, et al.
Scientific Reports|May 2, 2020
Genomic copy number variation correlates with survival outcomes in WHO grade IV gliomaZachary S Buchwald, Sibo Tian, Michael Rossi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain MetastasesRobert H Press, Danielle M Boselli, James T Symanowski, et al.
Cell Reports|February 10, 2018
Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8<sup>+</sup> T Cell Cross-PrimingDieke van Dinther, Henrike Veninga, Salvador Iborra, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2016
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cellsMaurizio Perdicchio, Juan M Ilarregui, Marleen I Verstege, et al.
Journal of Neuro-Oncology|November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgeryMudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.
Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Pageof 31